Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Shares Outstanding (2016 - 2025)

China Pharma Holdings' Shares Outstanding history spans 16 years, with the latest figure at $15.5 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 375.86% year-over-year to $15.5 million; the TTM value through Dec 2025 reached $15.5 million, up 375.86%, while the annual FY2025 figure was $15.5 million, 375.86% up from the prior year.
  • Shares Outstanding reached $15.5 million in Q4 2025 per CPHI's latest filing, up from $5.0 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $45.6 million in Q2 2021 to a low of $946791.0 in Q4 2021.
  • Average Shares Outstanding over 5 years is $7.0 million, with a median of $3.3 million recorded in 2024.
  • Peak YoY movement for Shares Outstanding: tumbled 89.18% in 2022, then surged 375.86% in 2025.
  • A 5-year view of Shares Outstanding shows it stood at $946791.0 in 2021, then surged by 420.81% to $4.9 million in 2022, then soared by 115.48% to $10.6 million in 2023, then crashed by 69.3% to $3.3 million in 2024, then surged by 375.86% to $15.5 million in 2025.
  • Per Business Quant, the three most recent readings for CPHI's Shares Outstanding are $15.5 million (Q4 2025), $3.3 million (Q3 2025), and $3.3 million (Q2 2025).